Dupilumab Safe, Effective in Kids With Moderate-to-Severe Asthma
Dupilumab (Dupixent, Sanofi and Regeneron) significantly reduced exacerbations compared with placebo...
Dupilumab an Option When Other Targeted Agents Fail in Aspirin-Exacerbated Respiratory Disease
NEW YORK (Reuters Health) – Dupilumab, a mon...
Less Peanut Allergy in Australia if Introduced Into Diet Earlier
NEW YORK (Reuters Health) – Peanut allergy h...
Bronchial Thermoplasty Benefits for Uncontrolled Asthma Sustained at 10 Years
NEW YORK (Reuters Health) – The benefits of ...
Hospitalizations for Food Anaphylaxis Triple, but Deaths Down
The rate of hospital admissions in the United King...